These coatings did not come from a sudden craze for trendy flowers among farmers, but from a charity campaign organized by the plastics company Trioworld over the years with the ARC (cancer research foundation). With pink, yellow or blue balloons, farmers can choose the type of research they want to fund: pink for breast cancer, yellow for childhood cancer, and blue for prostate cancer.
Over a million euros raised worldwide
The initiative, launched in France in 2016, was launched in New Zealand two years earlier and has been a great success with farmers in many countries, especially in Europe. In fact, the company that offers the color scheme funds the study up to 2 euros for each roll of plastic purchased: 1 euro from Trioworld and 1 euro from the distributor at no additional cost to the buyer. This approach has raised more than one million euros for various charities around the world. In France, the collected money is transferred annually on December 31st to the ARC fund. In total, in 2021, this amount amounted to several tens of thousands of euros.
The change in color does not affect the shelf life of the plastic and may even allow farmers to distinguish between different types of cuts and crops. “It’s a good way to be present in the countryside. In the city, we carry out all kinds of information campaigns, for example, with city lights. In rural areas, things are much more complicated,” says Gwendoline de Piedue, Project Manager for Science Communication at the ARC Science and Future Foundation. Because, in addition to the fact of directly funding research, this collaboration effectively allows, in an unusual way, to raise public awareness of this case, attracting their attention. We remind you that every year, according to the ARC Foundation, 59,000 new cases and 12,000 deaths from breast cancer should be regretted.
Research projects made possible by these donations
This year, the money raised has been used to fund new research or to continue existing ones. Donations dedicated to the fight against breast cancer supported a research project led by Dr. Celine Bourgeier of the Montpellier Regional Cancer Institute, which aims to develop a preventive treatment for breast radiation-induced fibrosis after surgery. This syndrome occurs in about 20,000 women each year, or about 40% of women who receive radiation therapy.
For pediatric cancers, the donations support a project led by Professor Stephane Ducasse of the Pellegrin Hospital in Bordeaux, which aims to evaluate the duo of immunotherapy and targeted therapy through clinical trials for children who fail or relapse.
Finally, this year, prostate cancer donations are being used to fund a project led by Nadir Bettache, a researcher at the Max Mousseron Institute for Biomolecules in Montpellier (CNRS), that will develop protective capsules that allow RNA to be transported into cancer. cells, making it possible to directly target cancer cells and suppress the production of a protein responsible for resistance to current treatments.